| George Ruiz, MD | |
|
100 N Academy Ave, Danville, PA 17822-2976 | |
| (570) 271-6523 | |
| (570) 271-8056 |
| Full Name | George Ruiz |
|---|---|
| Gender | Male |
| Speciality | Advanced Heart Failure And Transplant Cardiology |
| Experience | 26 Years |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306890090 | NPI | - | NPPES |
| 408355500 | Medicaid | MD | |
| 010208084 | Medicaid | VA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Medical Center | Danville, PA | Hospital |
| Mount Nittany Medical Center | State college, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.
Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).
Researchers are closer to developing therapies to combat the deadly tularemia infection, according to a study published this week in the Proceedings of the National Academy of Sciences' online Early Edition.
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
CIGNA Corp. recognizes the historical significance of the enactment of the Patient Protection and Affordable Care Act. The law will expand access to health insurance to many who currently do not have coverage.
› Verified 2 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.
Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).
Researchers are closer to developing therapies to combat the deadly tularemia infection, according to a study published this week in the Proceedings of the National Academy of Sciences' online Early Edition.
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
CIGNA Corp. recognizes the historical significance of the enactment of the Patient Protection and Affordable Care Act. The law will expand access to health insurance to many who currently do not have coverage.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George Ruiz, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | George Ruiz, MD 100 N Academy Ave, Danville, PA 17822-2976 Ph: (570) 271-6523 |
News Archive
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.
Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).
Researchers are closer to developing therapies to combat the deadly tularemia infection, according to a study published this week in the Proceedings of the National Academy of Sciences' online Early Edition.
Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
CIGNA Corp. recognizes the historical significance of the enactment of the Patient Protection and Affordable Care Act. The law will expand access to health insurance to many who currently do not have coverage.
› Verified 2 days ago
Dr. Stanley Joseph Russin, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-214-9585 Fax: 570-214-9519 | |
Dr. Steven Bonebrake, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-5555 Fax: 570-271-5269 | |
Tatiana Parra, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Paul Flavian Simonelli, MD, PH.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Mc 01-11, Danville, PA 17822 Phone: 570-271-6655 Fax: 570-214-3967 | |
Dr. Taher M. Yahya, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6393 Fax: 570-271-5623 | |
Dr. Ion D. Bucaloiu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Mark A Shelly, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6408 Fax: 570-271-5845 |